A Kaplan–Meier analysis indicated that the higher expression of TLX (NR2E1) correlates with shorter survival of NB patients, with a cutoff at 8.3, χ2=9.98, d.f.=1, P=0.0016 (Figure 7b). The gene discussed is NR2E1; the disease is neuroblastoma.